311 – 320 of 526
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Comparing 18 F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
(
- Contribution to journal › Article
-
Mark
Amyloid network topology characterizes the progression of Alzheimer's disease during the predementia stages
(
- Contribution to journal › Article
-
Mark
Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia
(
- Contribution to journal › Article
-
Mark
Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma
(
- Contribution to journal › Article
-
Mark
Genetic characterization of amyloid-β and tau network spread
(
- Contribution to journal › Article
-
Mark
Is longitudinal tau PET ready for use in Alzheimer's disease clinical trials?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Amyloid pathology in the progression to mild cognitive impairment
(
- Contribution to journal › Article
-
Mark
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Striatal changes in Parkinson disease : An investigation of morphology, functional connectivity and their relationship to clinical symptoms
(
- Contribution to journal › Article
-
Mark
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression : A study of fully automated immunoassays in BioFINDER and ADNI cohorts
(
- Contribution to journal › Article